EmStop begins CAPTURE-2 trial of embolic protection system
The trial will examine the EmStop system’s safety and performance as a cerebral embolic protection device.
Educating the medical device manufacturing industry since 2002.
The trial will examine the EmStop system’s safety and performance as a cerebral embolic protection device.
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns